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Abstract 
Background: To optimize patient outcomes, the patient-centred medical home
model emphasizes comprehensive team-based care. Pharmacists are qualiﬁed to
enhance appropriate medication use and help improve patient outcomes through
provision of medication therapy management (MTM) services. To optimally pro-
vide MTM, pharmacists must effectively collaborate with physicians. This study
explored factors that inﬂuence pharmacist-physician collaboration.
Methods and Findings: A convenience sample of ﬁve physicians participated in
semi-structured interviews and the resulting data were analyzed using qualitative
methods. Transcripts of the interviews were independently coded for themes by
two researchers. Five themes emerged: trustworthiness, role speciﬁcation, relation-
ship initiation, effects on practice, and professional awareness/expectations.
Conclusions: Overall interviewees spoke positively about pharmacists; however,
when discussing collaboration, they spoke almost exclusively about pharmacists
within their clinic. Since most pharmacists practice outside of clinics, bridging the
location gap is imperative for collaboration. In addition, physicians lacked an over-
all understanding of pharmacists’ training and clinical capacity. This may inhibit
pharmacists from participating to their full professional capability within inte-
grated healthcare teams. One approach to resolve this lack of physician under-
standing of pharmacists’ role and value may be to co-educate health professional
students. Further research is needed to explore ways to improve interprofessional
collaborative care.
Keywords: Medication therapy management; Interprofessional; Collaboration;
Pharmacist
Introduction
The U.S. healthcare system is in the midst of redeﬁning its approach to providing
patient care. To optimize patient outcomes, the patient-centred medical home model
emphasizes comprehensive, co-ordinated, team-based care [1]. Appropriate medica-
tion use improves outcomes in patients with chronic medical conditions, and phar-
macists are qualiﬁed to enhance appropriate medication use through provision of
medication therapy management (MTM) [2-7].
To optimally provide MTM, pharmacists must effectively collaborate with other
members of the healthcare team, including physicians. After assessing a patient’s
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drug-related needs, pharmacists may make recommendations for changes in pre-
scription medications, including, but not limited to, a recommendation to initiate
additional prescription medications, a change in the dose of a current medication, a
medication to be discontinued, or additional medication monitoring. Pharmacist
recommendations for changing prescription medications require the prescriber’s
approval. Therefore, pharmacist-physician collaboration is vital.
In addition to the need for the prescriber approval, collaboration between health-
care providers has the potential to improve patient outcomes and reduce overall
healthcare costs [8]. Pharmacists providing MTM services in our local community
were ﬁnding this collaboration to be challenging, particularly if the pharmacist was
providing MTM at a location separate from the physician practice. Previous research
determining factors impacting pharmacist-physician collaboration is limited [9-11].
Anecdotally, local MTM pharmacists at sites external to the physicians with
whom they shared mutual patients sought to collaborate with these physicians but
reported their efforts were not effective or efﬁcient. In an effort to improve this col-
laboration, they (including one study investigator) sought to understand the physi-
cians’ perceptions about collaboration with MTM pharmacists internal and external
to their practice settings.
The initial project, BRIDGE Phase I, was conducted in Duluth, MN, and included
physicians from a healthcare system who had experience working with both internal
and external MTM pharmacists [12]. The aim of the initial phase was to identify the
potential impact of practice location on pharmacist-physician collaboration. In par-
ticular, researchers aimed to measure the effect on collaboration if a pharmacist was
located off site (external) compared to those located within the same practice site
(internal). The results of Bridge Phase I were based on data collected from a group
of physicians completing a previously tested and validated survey, the Pharmacist-
Physician Collaborative Index (PPCI) [13]. Participants for Bridge Phase I were
selected based on their known history of interacting both with internal and external
pharmacists providing patient care (MTM).
BRIDGE Phase I evaluation was limited by small sample size (N = 11 respon-
dents) and the lack of qualitative data, but the PPCI scores did indicate the degree of
collaboration among physicians and pharmacists tended to be higher when they
practice within the same physical setting. BRIDGE Phase I did not, however, allow
participants to describe factors impacting their responses and their overall level of
collaboration with pharmacists.
Given the small sample size and limitations of the quantitative data from the ini-
tial BRIDGE Phase I study, the project was expanded to include collection of quali-
tative data. The purpose of this study expansion was to further explore factors that
inﬂuence pharmacist-physician collaboration from the physician perspective.
Methods
Study design and participant recruitment
The study was a critical-theory-based investigation to further evaluate the relation-
ship between physicians and pharmacists based on physician perceptions of the role
of pharmacists in the healthcare team. The study was conducted using semi-struc-
tured interviews and thematic analysis. Invited participants included physicians who
participated in BRIDGE Phase I [12]. Participating physicians who enrolled in Phase
II of this project were asked to provide contact information so that a semi-structured
interview could be scheduled. Physicians were offered a $150 gift card to a local
retailer for participating in the interview process. A total of seven out of the 11 (64%)
participants provided contact information indicating interest in participation in
Phase II.
Potential participants were contacted using the preferred form of contact they
indicated during the enrollment period, either through email or a telephone call. The
interviewer performed the initial contact and worked with the potential participants
to schedule a one-hour face-to-face interview at the preferred location and time for
the interviewees.
The interviewer was a non-practicing clinical pharmacist who had no personal or
professional relationships with any of the participants. Participants were not made
aware of the moderator’s professional background at the onset of interviews and
were informed to answer as honestly as possible. The interviewer asked a set of open-
ended questions (Appendix A) focused on the following areas: development of trust-
worthiness, professional role specification, and relationship initiation adapted from the
PPCI (Appendix B) [11,13]. The sessions were audio recorded and manually tran-
scribed using an external transcription service.
Data analysis
Thematic analysis was conducted using the transcripts from the recorded interviews.
Two researchers independently reviewed the transcripts to identify themes.
Following their initial review of the transcripts, they discussed the emerging themes,
reconciled differences in the proposed themes, and established the coding frames. In
addition, the researchers formulated deﬁnitions for each coding frame, which they
used to guide their coding. The transcripts were then independently coded using
those deﬁned coding frames. All coding was evaluated and differences were recon-
ciled. The ﬁnal coded transcripts were used as a basis for the data analysis.
Results
Of the 11 respondents to BRIDGE Phase I, seven provided contact information indi-
cating possible interest in participating in the BRIDGE Phase II semi-structured
interview. Of those seven, ﬁve consented and participated in the interviews, which
took place between July 2011 and May 2012. Each interview lasted approximately 45
minutes. The interviews took place at the practitioners’ clinic site in either their ofﬁce
or a conference room.
Five coding frames emerged:
Trustworthiness
Any discussion relating to the realization or existence of assured reliance on the charac-
ter, ability, strength, or truth of pharmacists as perceived by the physician.
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Overall, interviewees described pharmacists as trustworthy individuals. Some
interviewees differentiated between internal and external pharmacists.
I have not found any pharmacist to be untrustworthy. I have found
them to be a very dedicated people who are trying to do a good job, and
I haven’t found any that I think lack the skills or professionalism. (P1)
I trust the internal ones more. I should clarify that by saying I don’t
distrust the external ones, but just by virtue of personally associating
with [internal pharmacists], you build up a level of trust. (P2)
I work in an integrated system, so we are highly integrated. It’s hospi-
tal and clinic, and we have credentialing, and we have a whole process
to say somebody is really quality or not. That’s the ﬁrst step. It’s not
somebody off the street. It’s someone whom we vetted, so we know
that our PharmDs are part of that team. That is part of that deal. (P4)
Relationship Initiation
Discussions regarding the development of communication/dialogue between the phar-
macist and the physician focused on building a rapport between both professionals.
Comments related to relationship initiation varied considerably. Interviewees
commented on the ability to have face-to-face interactions and a brief summary of
pharmacists’ recommendations when collaborating with internal pharmacists. In
contrast, when discussing pharmacists external to their practice, interviewees
described a lack of knowledge of who these external pharmacists were.
Once in a while I will call a pharmacy, but I don’t know who I’m speak-
ing to at a pharmacy on prescribing issues. … I get the MTM [medica-
tion therapy management] paperwork for patients who are [being
seen at an external MTM clinic]. … I will get several pages … but I
haven’t personally interacted with them by phone or anything. (P2)
I almost never refer now to a pharmacist outside of our institution
because we have them so handy. Normally, I start out with [internal
MTM pharmacists], and then they may refer me on or refer the prob-
lem, usually. If they can’t answer the question, they will refer the
problem on to someone else who is in [sic] the staff. (P1)
Usually, I’ll ask them why and what [internal MTM pharmacists’]
thoughts are, and then we talk about it and come to a compromise. (P5)
One interviewee described the relationship developed with internal pharmacists
as obligatory.
I don’t do a lot of interaction per se, other than writing prescriptions,
but here, of course, we have this thing … that the pharmacist sees my
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patients without my express consent. They see my patients, and they
try to tell me from their perspective, so that is basically the interac-
tion I have. (P3)
Professional awareness/expectations
Discussions highlighting the physician’s understanding of a pharmacist’s education
level, clinical capabilities, and general knowledge of medicine/patient care.
The interviewees described their understanding of pharmacist training and clini-
cal capability.
They are often very current on current medications. (P1)
Most of our MTMs have been PharmD. I don’t know if it’s a special
degree to be an MTM or not. (P4)
So pharmacists’ expertise focused on the hard science and hard
numbers, and I don’t think actually dealing with the patients. (P3)
A pharmacist is not trained in dealing with patients directly. I don’t
know about the current time. In fact, I think a lot of things have
changed since I was in school. (P3)
I’m going to guess, I think it’s three years. I think there are three-year
residencies that you can do … ﬁrst, second, and third year. That’s
what I think, but I’m not sure. You get a bachelor’s degree before that.
I think it’s three years at the school of pharmacy. I don’t know;
maybe it’s four. (P4)
Interviewees went on to describe what they thought occurred during pharmacist-
patient interactions and how a pharmacist approaches care of patients.
We do go over some of the same things. (P1)
Patients, I think, just enjoy being able to ask questions. I’m not sure
that I know the full nature of the discussions that occur with them,
but I would say the feedback from patients, the majority is very pos-
itive. … I presume, are asking questions about how I take meds and
the side effects and interactions, so it’s those sorts of things. I think
that the beneﬁt is perceived more by the patients, just to have that
full period of time with them. (P2)
My goal is try to get the patient to feel better, not just physically but
mentally. And then, everybody knows that not all medication really
does what it’s supposed to do. Then there are plenty of medications
in the market that probably should not be in the market. When a
pharmacist approaches those problems, they approach them from
purely factual information on this. (P3)
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Evaluating medication side effects, making suggestions as far as
other options, evaluating how effective medications are. (P5)
Role specification
Discussions establishing normative responsibilities for pharmacists within the “collabo-
ration” with the physician.
Interviewees primarily described the pharmacists’ roles as complementary, aug-
menting physician-provided care.
Now, as we have been making formalized healthcare teams, we see
the PharmDs as being an integral part of that team, regarding med
management and being able to look at the meds and give us feed-
back on the use of the meds and how we are prescribing them. (P4)
They go in, see the patient. … I’m usually seeing another patient at that
time, and then we try to co-ordinate afterwards so that we can be ver-
bally one-on-one with each other and they tell me what they have in
mind. They also ﬁll out a little sheet of their suggestions for changes. (P1)
Usually they will see patients prior to a visit … then half the time
they will stop by and we will just go over things and they will make
some recommendations or comments. Sometimes we can’t catch
each other because they’ve got another appointment, or I’m in an
exam room, so they will scribble some notes for me on a standard
format and leave that for me with the patient’s room and papers, and
I will review that before I see the patient. (P2)
They also put on, most Tuesdays of the week, a little educational
update, particularly on new medications. (P1)
They see our patients. Usually, they’ll see patients that are discharged
from the hospital. They’ll see them before the visit and then collabo-
rate with me before I go in. They see our diabetic patients and also
patients who are on multiple medications at least once a year.
They’re also available for consultations, so any time we want to have
a consultation as far as pharmacists, we can just put a referral in and
then they’ll be available for that. We also have a program that’s start-
ing where they can see patients that are started on medications for
hypertension, and then they can see them for follow-up, and then
titrate those medications according to protocol, so they’re going to
be doing it for blood pressure and for cholesterol now. Then I sus-
pect they may be doing it for other things, too, but that’s the initial
diseases that we’re using them for. (P5)
One interviewee described the pharmacists’ role as potentially duplicative or
unnecessary for direct patient care.
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Often times they tell me what the lab ﬁnding is, what the patient is
complaining of; those things I don’t need to know because I will ﬁnd
them myself.
And again, I don’t believe it’s pharmacy’s work to clean up my med-
ications. That is wrong; I have to do my part.
As far as the kind of role that I would like to see for pharmacist, it is
just a very complicated thing. I would like the option of asking phar-
macists, please look into this, instead of them cutting back some pro-
tocol of someone that had only two medications … Some that are
really complicated, I should do my own homework … my content
and then I would like to have the pharmacist kind of look through
the list. But I’m really not sure if they should see the patient them-
selves. (P3)
While discussing the role of external pharmacists, interviewees described interac-
tions with community pharmacists (versus pharmacists providing MTM services).
As far as my interaction with other pharmacists, that is pretty much
via fax, so I don’t get a one-on-one with them. Usually, they fax some-
thing to us or they will fax certain material or certain prescriptions,
and often they will have suggestions on that or they will have certain
interactions that they want to make sure that I’m aware of before I
OK the prescription or re-OK the prescription.
It’s interesting that prior to their coming I didn’t really avail myself
of the pharmacists at the commercial sites, because I didn’t really
think that was their job to do my research for them. (P1)
Effects on practice
Discussions on the impact of the current level of pharmacist-physician collaboration
(or theoretical expansion of collaboration) on the physician’s practice.
Interviewees primarily spoke of the pharmacist’s ability to answer clinical ques-
tions and to impact patient satisfaction.
I think the beneﬁts are really perceived by the patient … so if my
patients are happy with it then I’m happy with it.
They are a great resource if we have questions. (P2)
I think they help us in answering the med questions that happen
with patients, and I think taking the time with patients for them to
understand their meds and help them.
As a great asset, yes, and it makes our job easier, quite frankly.
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I didn’t realize how much I needed a pharmacist until we had them
on staff, and then I found them so valuable I know don’t know how
we would live without them.
They also get into, sometimes, the vaccinations as well and suggest
certain vaccinations that a patient has, and I ﬁnd that immensely
helpful. I go over some of the same things, but occasionally you miss
things, and they often have good suggestions.
They are often very current on current medications. Most recently, a
patient came in … Citalopram 60mg a day, and they are current on
the fact that, hey, QT interval prolongation—I just learned that from
them today—so that prompted me to do an ECG, where I could
check out the QT interval and make sure that is not a problem with
this particular patient. I had an old ECG to compare it with, so that
was helpful. So they are helpful in that regard.
I think to make sure that we are both are up on the changes in indi-
cation and the changes in contraindication. I think that is their most
valuable service. (P1)
I think they help us in answering the meds that happen with
patients, and I think taking the time with patients for them to under-
stand their meds and help them. But then to emphasize the disci-
pline for them being accountable for their meds and the taking of
their meds, I think is really important. I think that is time down the
line for the primary care Doc: there is so much that goes wrong with
patients related to their medications. It’s huge. Yes, taking the time to
get that down is really important. (P4)
Pharmacy, I love my pharmacists. I think it’s deﬁnitely a necessary
ﬁeld, and they’ve deﬁnitely added to my practice, as far as being
available to answer questions. I deﬁnitely think they’re necessary.
I think from the feedback they give, when the patients come back, re-
evaluating how they are after medication changes. They deﬁnitely come
up with things that I don’t think of, or are able to identify things right
away that maybe it’s hard to ﬁt into a short visit, so it is helpful. (P5)
Some interviewees also described how a pharmacist’s care could impact physician
practice unfavourably.
Our only problem sometimes in the clinic situation is if the patient
arrives late, and the pharmacist has 30 minutes beforehand, and then
I’m put 30 minutes behind, so as a trickle-down effect of putting doctors
behind, there is some resistance among doctors to it for that very reason.
Journal of Research in Interprofessional Practice and Education
Journal of Research in
Interprofessional 
Practice and
Education
Vol. 5.2
June 2015
www.jripe.org
8
Bridge II: Physician-
Pharmacist
Collaboration
Hager, Uden, &
Tomazewski 
There are some patients who are a little antagonistic to taking that
much time out of their schedule to come a half-hour early and to do
this, and some will refuse. Some have seen a pharmacist, perhaps a
year before, and say I don’t need it. Some just do not want to take the
time to do it, so that’s the only stumbling block I see to that. (P1)
I don’t know that there are drawbacks. Sometimes a pharmacist res-
ident will focus on things that I think would be less helpful to me.
Aspirin for primary prevention sometimes, there are some things
that I think the answers are less clear. Calcium supplements as well,
too. You can ask ten Docs and get eleven different opinions there, so
I think that sort of input for some primary prevention things is less
helpful, but I don’t think it’s necessarily bad. I don’t think it’s a bad
thing though. (P2)
From my perspective, I don’t ﬁnd it [pharmacists meeting with
patients] very useful.
Patients actually ask “why do I have to see the pharmacist?” I don’t
want to say I want you to see them because that’s not true, but I don’t
also want to also say because it’s a protocol and then say why should
I pay for this, and have them asking “are you not competent enough
to manage my medication, as a doctor?” And this does come up
sometimes, and that is one problem.
The other problem is that the pharmacist makes one recommenda-
tion, but I don’t agree with it in a lot of patients, because, again, you
look at the factual, and in many cases it does apply in real life, so I
will ﬁnd myself trying to justify pharmacists … for the patients. (P3)
Discussion
A number of factors that impacted physicians’ perceptions of collaboration or their
willingness to collaborate with pharmacists were identiﬁed. Not surprisingly, these
factors included trustworthiness, relationship initiation, and role speciﬁcation, which
were the three themes from the PPCI on which our structured interview questions
were based [11,13]. In addition to these, two additional factors emerged, including
professional awareness/expectations and effects on practice. However, all of these fac-
tors appear to be solely directed at collaboration with internal pharmacists. It is
unclear if the factors related to the ﬁve coding themes also pertain to external phar-
macists because the majority of comments were in reference to internal pharmacists.
For the themes of trustworthiness and relationship building, physicians did note
that all pharmacists were generally trustworthy. However, they did differentiate
between internal and external, with internal pharmacists being described as gener-
ally more trusted. When discussing relationship building, participants stated that lit-
tle to no relationship existed with external pharmacists. Building trust and
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relationships between external pharmacists and physicians may best be accom-
plished through increased interaction.
Perceived effects of pharmacists on a physician’s medical practice also appeared
to impact collaboration. Physicians noted that pharmacists working internally were
incorporated into the daily workﬂow. They wrote patient notes in the internal elec-
tronic health record or spoke directly with the physician prior to their patient inter-
action. Not being incorporated into usual clinic workﬂow appears to have created a
negative perception of the external pharmacists’ effect on practice. Developing tech-
niques to integrate pharmacists’ recommendations into usual workﬂow and docu-
mentation may improve overall collaboration.
The unclear role speciﬁcation and lack of knowledge about pharmacists’ clinical
education were additional factors that appear to impact physician-pharmacist collabo-
ration. Physicians stated they were unclear about what took place during the pharma-
cist-patient visits. Some described their role as duplicative, while others described it as
adding a unique perspective. In addition, the lack of understanding of pharmacists’
education was explicitly identiﬁed as a reason for one physician’s unwillingness to col-
laborate with pharmacists who provided direct patient care. Other physicians were
unable to accurately depict the education and abilities of pharmacists. One approach
to improving role speciﬁcation and knowledge about pharmacists’ clinical education
may be through the increased use of interprofessional education and additional out-
reach to physician groups describing the professional capabilities of pharmacists.
In general, interviewees spoke positively about interactions with pharmacists.
However, when interviewees focused on collaboration, they spoke almost exclusively
about the pharmacists working within their clinic. The physicians’ focus on internal
pharmacists during the majority of their commentary implies that the level of collab-
oration is disparate between internal and external pharmacists. This aligns with
BRIDGE Phase I results, where only 36% of survey respondents completed the por-
tion of the survey asking about collaboration with external pharmacists [8]. Unless
the interviewer directly asked the participants to consider external pharmacists, the
physicians spoke solely about the pharmacists embedded in their practice. Those
who did acknowledge some sort of past interaction with external pharmacists still
focused their responses on collaboration with the internal pharmacists. This lack of
collaboration with external pharmacists appeared to impact physicians’ willingness
to accept or consider their recommendations. One physician noted that when s/he
received recommendations from an external MTM pharmacist s/he doesn’t “read
them always in detail, but kind of jump[s] to the end to see what their lower-play rec-
ommendations are.” (P2)
Since the majority of pharmacists do not practice within physician clinics, bridg-
ing the location gap is imperative for pharmacist-physician collaboration.
Pharmacists providing MTM services often seek collaboration with physicians that
provide care for mutual patients to more effectively care for those patients. These
pharmacists have struggled to establish a meaningful collaborative relationship.
Pharmacists need to collaborate with physicians to optimize the effectiveness of
MTM services and improve patient outcomes. However, physicians may not perceive
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the need to collaborate with pharmacists, particularly external pharmacists, and there-
fore may not seek collaboration.
This study is limited by a small convenience sample of physicians from one health-
care system, and therefore may not be generalizable to other contexts or settings.
Conclusion
There is limited research that pertains to physician-pharmacist relationships and the
delivery of MTM services. McGrath and colleagues conducted focus groups with a
small random sample of physicians who were not related to an MTM clinic [14]. After
a presentation reviewing the core principles of MTM services, a series of questions
related to the themes of medication needs, collaboration regarding medication issues,
the overview of MTM, and communication of MTM were asked. Consistent with the
present study, the physicians mentioned that established and trusting relationships as
well as the close proximity of the pharmacist were essential for the success of MTM.
Similarly, in an established MTM program, within a large medical centre, physicians
would use pharmacist services more if they were readily available in the clinic [15].
They suggested that the use of telemedicine technology may alleviate the access issue.
In this study, the interviews provided insight into physician perspectives of fac-
tors that may inﬂuence collaboration with pharmacists. In general, interviewees
spoke positively about interactions with pharmacists. However, when interviewees
focused on collaboration, they spoke almost exclusively about the pharmacists work-
ing within their clinic. Since the majority of pharmacists do not practice within
physician clinics, bridging the location gap is imperative for pharmacist-physician
collaboration in patient care. This may inhibit pharmacists contributing to their full
professional capability within integrated healthcare teams. One approach to resolve
this lack of physician understanding of pharmacists’ role and value may be to co-edu-
cate health professional students. In addition, developing techniques that help to vir-
tually insert external pharmacists into the standard workﬂow of clinics using
internal MTM pharmacists may also help reduce the burden of collaboration placed
on physicians. Further research is needed to explore ways to improve interprofes-
sional collaborative care and develop methods to alleviate some of the barriers that
may currently exist.
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Appendix A: Core structured interview questions
Tell me a little bit about your practice. [Take less than 5 minutes for this
question]
Can you tell me a little about how you work and interact with
pharmacists during a typical day or week?
Thank you for telling me about the interactions you have with
pharmacists. Do any of these pharmacists beneﬁt you or your practice
more than others? Why? *Do any of these pharmacists negatively
impact your practice? If so, how? [New after ﬁrst three interviews]
I would now like to have you think about a person with whom you
have a trusting relationship within your practice. 
Why do you trust this person? [Note to interviewer: Try to draw out
characteristics]—why trust? Collaboration? How did this
collaboration begin?
Do any pharmacists that you work with display any of these same
trust characteristics?
What role should the [insert preferred pharmacist title here] play on a
patient’s healthcare team? Do you see them as a consultant for speciﬁc
situations, or should they be part of every patient’s primary care? How
should the [insert preferred pharmacist title here] initiate this role in
your opinion?
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Appendix B: Physician–Pharmacist Collaboration 
Index (PPCI) items [11,13]
Trustworthiness
The pharmacist is credible.
I trust this pharmacist’s drug expertise.
I can count on this pharmacist to do what he/she says.
Communication between this pharmacist and myself is two-way.
I intend to keep working together with this pharmacist.
My interactions with this pharmacist are characterized by open
communication of both parties.
Role specification
This pharmacist and I negotiate to come to agreement on our activities
in managing drug therapy.
This pharmacist and I are mutually dependent on each other in caring
for patients.
I will work with this pharmacist to overcome disagreements on
his/her role in managing drug therapy.
In providing patient care, I need this pharmacist as much as this
pharmacist needs me.
This pharmacist depends on me as much as I depend on him/her.
Relationship initiation
This pharmacist has spent time trying to learn how he/she can help you
provide better care.
This pharmacist has provided information to you about a speciﬁc
patient.
This pharmacist has showed an interest in helping you improve your
practice.
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